Save information for later
Sign Up

Learn About Ciliary Dyskinesia-Bronchiectasis

What is the definition of Ciliary Dyskinesia-Bronchiectasis?
Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by chronic respiratory tract infections. In individuals with primary ciliary dyskinesia, the tiny hair-like structures (cilia) that protect the lungs and other tissues have mutations that prevent them from working properly, eventually leading to a condition where the bronchial tubes in the lungs are permanently damaged (bronchiectasis).
What are the symptoms of Ciliary Dyskinesia-Bronchiectasis?
Symptoms of primary ciliary dyskinesia include a persistent wet cough from birth or infancy, neonatal respiratory distress, shortness of breath, wheezing or whistling upon breathing, recurrent chest colds, asthma, chronic nasal drainage, hearing problems, and chronic infections in the ears, sinuses, and lungs that eventually lead to the development of bronchiectasis (permanent bronchial tube damage). Additional symptoms may include infertility or a condition where organs, such as the heart, liver, or other organs, are either reversed in the body (situs inversus) or abnormally formed.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Ciliary Dyskinesia-Bronchiectasis?
While there is no cure for primary ciliary dyskinesia, treatment is focused on alleviating symptoms and may include antibiotics for sinus or lung infections, bronchodilators, steroids, and mucous thinners (mucolytics), oxygen therapy, airway clearance techniques, speech therapy, hearing aids, and physical therapy. Surgery may be necessary to correct any heart defects, while lung transplantation may be considered for patients with severe, advanced bronchiectasis (permanently damaged bronchial tubes).
Who are the top Ciliary Dyskinesia-Bronchiectasis Local Doctors?
Doreen J. Addrizzo-Harris
Experienced in Ciliary Dyskinesia-Bronchiectasis
Experienced in Ciliary Dyskinesia-Bronchiectasis

New York University

111 Broadway, 
New York, NY 
 (24.6 mi)
Experience:
36+ years
Languages Spoken:
English
Offers Telehealth

Doreen Addrizzo-Harris is a Pulmonary Medicine provider in New York, New York. Dr. Addrizzo-Harris has been practicing medicine for over 36 years and is rated as an Experienced provider by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. Her top areas of expertise are Bronchiectasis, Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, and Lung Metastases.

Advanced in Ciliary Dyskinesia-Bronchiectasis
Pulmonary Medicine | Intensive Care Medicine | Emergency Medicine
Advanced in Ciliary Dyskinesia-Bronchiectasis
Pulmonary Medicine | Intensive Care Medicine | Emergency Medicine
2525 Kings Hwy, 
Brooklyn, NY 
 (24.9 mi)
Languages Spoken:
English

Gene Pesola is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Brooklyn, New York. Dr. Pesola and is rated as an Advanced provider by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. His top areas of expertise are Ciliary Dyskinesia-Bronchiectasis, Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), and Lung Metastases.

 
 
 
 
Learn about our expert tiers
Learn More
Pulmonary Medicine
Pulmonary Medicine
124 E Mount Pleasant Ave, 
Livingston, NJ 
 (20.1 mi)
Languages Spoken:
English

Martin Greenberg is a Pulmonary Medicine provider in Livingston, New Jersey. Dr. Greenberg and is rated as an Experienced provider by MediFind in the treatment of Ciliary Dyskinesia-Bronchiectasis. His top areas of expertise are Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, and Pleural Effusion.

What are the latest Ciliary Dyskinesia-Bronchiectasis Clinical Trials?
Primary Ciliary Dyskinesias: Identification of Specific Severity Criteria and Phenotype-genotype Correlation Study

Summary: Primary Ciliary Dyskinesias (PCD) are rare, autosomal recessive respiratory diseases, due to a defect in mucociliary clearance linked to abnormalities in the structure and/or function of the cilia. The variety of ciliary abnormalities identified reflects the genetic heterogeneity of PCDs. The thirty or so genes currently implicated explain the pathology in about half of the patients. PCDs are char...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)

Summary: The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.